D. Clive

8.1k total citations · 1 hit paper
47 papers, 2.3k citations indexed

About

D. Clive is a scholar working on Molecular Biology, Cancer Research and Genetics. According to data from OpenAlex, D. Clive has authored 47 papers receiving a total of 2.3k indexed citations (citations by other indexed papers that have themselves been cited), including 24 papers in Molecular Biology, 21 papers in Cancer Research and 8 papers in Genetics. Recurrent topics in D. Clive's work include Carcinogens and Genotoxicity Assessment (19 papers), Chronic Lymphocytic Leukemia Research (8 papers) and Acute Lymphoblastic Leukemia research (8 papers). D. Clive is often cited by papers focused on Carcinogens and Genotoxicity Assessment (19 papers), Chronic Lymphocytic Leukemia Research (8 papers) and Acute Lymphoblastic Leukemia research (8 papers). D. Clive collaborates with scholars based in United States, United Kingdom and Germany. D. Clive's co-authors include Martha M. Moore, A. G. Batson, John Hozier, Jeffrey R. Sawyer, Martha McClellan Brown, K. Johnson, W.G. Flamm, Barry E. Howard, Naomi J. Bernheim and Paul Glover and has published in prestigious journals such as Trends in Biochemical Sciences, Environmental Health Perspectives and Annals of the New York Academy of Sciences.

In The Last Decade

D. Clive

46 papers receiving 2.1k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Validation and characterization of the L5178Y/TK+/- mouse lymphoma mutagen assay system

1979 438 citations D. Clive, K. Johnson et al. Mutation Research/Fundamental and Molecular Mechanisms of Mutagenesis profile →

Peers

Countries citing papers authored by D. Clive

Since Specialization

Citations

This map shows the geographic impact of D. Clive's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by D. Clive with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites D. Clive more than expected).

Fields of papers citing papers by D. Clive

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by D. Clive. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by D. Clive. The network helps show where D. Clive may publish in the future.

Co-authorship network of co-authors of D. Clive

This figure shows the co-authorship network connecting the top 25 collaborators of D. Clive. A scholar is included among the top collaborators of D. Clive based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with D. Clive. D. Clive is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	The L5178Y/tk+/− mouse lymphoma specific gene and chromosomal mutation assay 1997 ·Mutation Research/Genetic Toxicology and Environmental Mutagenesis ·Ann D. Mitchell, Angela E. Auletta, D. Clive, Paul E. Kirby, Martha M. Moore, B. Myhr	89
2	Mouse lymphoma workshop: Victoria, British Columbia, Canada, March 27, 1996 Protocol issues regarding the use of the microwell method of the mouse lymphoma assay 1997 ·Environmental and Molecular Mutagenesis ·Toshio Sofuni, (unknown), Hiroyasu Shimada, Julie Clements, Masamitsu Honma, D. Clive, Michael Green, Véronique Thybaud, Richard H.C. San, B.M. Elliott, Lutz Müller	10
3	Consensus agreement regarding protocol issues discussed during the mouse lymphoma workshop: Portland, Oregon, may 7, 1994 1995 ·Environmental and Molecular Mutagenesis ·D. Clive, George Bölcsföldi, Julie Clements, Jane Cole, (unknown), Jenness B. Majeska, Martha M. Moore, Lutz Müller, B. Myhr, T.J. Oberly, (unknown), Colette J. Rudd, Hiroyasu Shimada, Toshio Sofuni, Véronique Thybaud, (unknown)	36
4	potent clastogenicity of the human carcinogen etoposide to the mouse bone marrow and mouse lymphoma L5178Y cells: Comparison to salmonella responses 1994 ·Environmental and Molecular Mutagenesis ·J. Ashby, H. Tinwell, Paul Glover, P. Poorman‐Allen, (unknown), R.D. Callander, D. Clive	44
5	Use of microsatellite DNA polymorphisms on mouse chromosome 11 for in vitro analysis of thymidine kinase gene mutations 1994 ·Mutagenesis ·(unknown), (unknown), John Hozier, D. Clive	17
6	A Double-Blind, Placebo-Controlled Cytogenetic Study of Oral Acyclovir in Patients with Recurrent Genital Herpes 1991 ·The Journal of Infectious Diseases ·D. Clive, Lawrence Corey, Richard C. Reichman, L. Gray Davis, John Hozier	8
7	Localization of the mouse thymidine kinase gene to the distal portion of chromosome 11 1991 ·Genomics ·John Hozier, (unknown), Jeffrey R. Sawyer, (unknown), (unknown), D. Clive, Martha M. Moore	18
8	The potent hepatocarcinogen methapyrilene induces mutations in L5178Y mouse lymphoma cells in the apparent absence of DNA adduct formation 1991 ·Mutation Research Letters ·Daniel A. Casciano, Glenn Talaska, D. Clive	21
9	Stability of tk−/− mutants of L5178Y mouse lymphoma cells in Fischer's medium 1991 ·Mutation Research/Genetic Toxicology ·D. Clive, (unknown)	1
10	Molecular aspects of chemical mutagenesis in L5178Y/tk+/− mouse lymphoma cells 1990 ·Mutagenesis ·D. Clive, Paul Glover, (unknown), John Hozier	64
11	Procarbazine is a potent mutagen at the heterozygous thymidine kinase (tk^+/−) locus of mouse lymphoma assay 1988 ·Mutagenesis ·D. Clive, NA Turner, (unknown)	13
12	Analysis of trifluorothymidine-resistant (TFTr) mutants of L5178Y/TK+/− mouse lymphoma cells 1985 ·Mutation Research/Fundamental and Molecular Mechanisms of Mutagenesis ·Martha M. Moore, D. Clive, John Hozier, Barry E. Howard, A. G. Batson, (unknown), Jeffrey R. Sawyer	130
13	Chromosome 11 aberrations in small colony L5178Y TKPsu−/− mutants early in their clonal history 1985 ·Mutation Research/Environmental Mutagenesis and Related Subjects ·John Hozier, Jeffrey R. Sawyer, D. Clive, Martha M. Moore	92
14	Cytogenetic analysis of the L5178Y/TK+/− → TK−/− mouse lymphoma mutagenesis assay system 1981 ·Mutation Research/Fundamental and Molecular Mechanisms of Mutagenesis ·John Hozier, Jeffrey R. Sawyer, Martha M. Moore, Barry E. Howard, D. Clive	130
15	Validation and characterization of the L5178Y/TK+/- mouse lymphoma mutagen assay system breakdown → 1979 ·Mutation Research/Fundamental and Molecular Mechanisms of Mutagenesis ·D. Clive, K. Johnson, (unknown), A. G. Batson, Martha McClellan Brown	438
16	Evidence for chemically-induced structural gene mutations at the thymidine kinase locus in cultured L5178Y mouse lymphoma cells 1977 ·Mutation Research/Fundamental and Molecular Mechanisms of Mutagenesis ·D. Clive, Peter Voytek	48
17	Mutagenicity of thioxanthenes (hycanthone, lucanthone and four indazole derivatives) at the TK locus in cultured mammalian cells 1974 ·Mutation Research/Fundamental and Molecular Mechanisms of Mutagenesis ·D. Clive	27
18	Recent developments with the L5178Y TK heterozygote mutagen assay system. 1973 ·Environmental Health Perspectives ·D. Clive	45
19	Mutagenicity of hycanthone in mammalian cells 1972 ·Mutation Research/Fundamental and Molecular Mechanisms of Mutagenesis ·D. Clive, W.G. Flamm, (unknown)	51
20	A mutational assay system using the thymidine kinase locus in mouse lymphoma cells 1972 ·Mutation Research/Fundamental and Molecular Mechanisms of Mutagenesis ·D. Clive, W.G. Flamm, (unknown), Naomi J. Bernheim	199

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact